{
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "complex_factors": [
        "Synthetic replication via collateralised ETP structure",
        "Use of options-based income strategy on underlying equities",
        "Leverage inherent in product design",
        "Counterparty and collateral risk exposure",
        "No capital protection and potential for total loss",
        "Requires specific investor knowledge and experience"
    ],
    "classification": "complex",
    "supporting_data": "The product is a Collateralised Exchange Traded Securities (ETP) linked to an options-based income strategy on seven large-cap US tech stocks (Amazon, Apple, Alphabet, Meta, Microsoft, Tesla, Nvidia). The KIID explicitly states the product is 'not simple and may be difficult to understand' and is intended for investors with specific knowledge or experience. The investment strategy involves holding underlying assets in a margin account with collateral assets including cash and short-term sovereign debt, indicating synthetic replication rather than physical ownership. The product exposes investors to counterparty risk and collateral liquidation risk, with no capital protection and potential for total loss. The risk indicator is medium-low (3/7), but the product uses leverage and derivative instruments (options) inherently in its strategy. The product is not UCITS compliant. Costs include transaction costs related to buying and selling underlying investments, consistent with derivative usage. The product\u2019s complexity is driven by its synthetic structure, use of options (derivatives), leverage, counterparty risk, and the need for investor sophistication. There is no mention of inverse or multiple leverage (2x/3x), but leverage is inherent in the options-based strategy. The product\u2019s complexity is further supported by the absence of capital protection and the requirement for investors to understand derivative risks and collateral management. The product\u2019s classification as complex aligns with MiFID II criteria due to synthetic replication, derivative use, leverage, and counterparty risk exposure."
}